Jumat, 01 Desember 2017

Could BMS' immuno-oncology hit Opdivo also attack HIV? - FierceBiotech


FierceBiotech

Could BMS' immuno-oncology hit Opdivo also attack HIV?
FierceBiotech
Researchers in France are investigating whether Opdivo, a checkpoint inhibitor approved to fight some cancers, might also work in HIV. Share Facebook Twitter LinkedIn Email Print. When doctors in Paris treated an HIV-infected lung cancer patient with ...
Case Study: Cancer Drug Delivers Shock HIV ImprovementDaily Beast
Bristol-Myers Squibb takes Opdivo to China's FDA after lung cancer survival winFiercePharma

all 8 news articles »


from Health - Google News http://ift.tt/2i5E9Xw


EmoticonEmoticon

:)
:(
hihi
:-)
:D
=D
:-d
;(
;-(
@-)
:o
:>)
(o)
:p
:-?
(p)
:-s
8-)
:-t
:-b
b-(
(y)
x-)
(h)